The global Microbiome Therapeutics Market was valued at USD 132.94 million in 2023 and is poised to reach an estimated USD 1,979.94 million by 2031, marking a remarkable compound annual growth rate (CAGR) of 40.16% from 2024 to 2031. This exponential growth is driven by the increasing focus on the human microbiome, technological advancements in microbiome research, rising prevalence of chronic diseases, and expanding investment in microbiome-based therapeutic solutions.Get A Free Sample Report on Microbiome Therapeutics Mar...
more